- Ambrosia LLC, led by Jesse Karmazin, has begun commercial “young-blood” plasma transfusions: elderly clients pay ~US $8,000 for 1.5 L of plasma harvested from young donors, prompting discussion of the 200× markup over raw plasma value.  
- Synthetic-neurobiology lab (Boyden group) released four pre-prints: temporally interfering electric fields for non-invasive deep-brain stimulation, wide-field three-photon excitation for large-volume imaging, nucleotide-time alignment for molecular recorders, and cell-diversity mapping in photosensitive human brain organoids.  
- Arigos Biomedical was highlighted for its work on cryopreservation and distribution protocols for rare human organs and tissue samples, aiming to improve transplant logistics and research access.  
- IDT DNA announced its 2017 Synthetic Biology Grant program, offering free gene synthesis resources to academic and non-profit open-science projects.  
- A Medium post on practical zero-knowledge SNARKs (zkSNARKs) was shared as a primer for privacy-preserving computation in decentralized systems.